GL1X · GenesisL1 explorer

MolNFT v1 · #49553 · protein

Glycogen phosphorylase B in complex with (1R)-3'-(4- methylphenyl)-SPIRO[1,5-anhydro-D-glucitol-1,5'- isoxazoline]

2QRQ · Glycogen phosphorylase, muscle form: “Glycogen phosphorylase B in complex with (1R)-3'-(4- methylphenyl)-SPIRO[1,5-anhydro-D-glucitol-1,5'…”. X-ray diffraction, 1 ligand (S13), 11 pockets (best druggability 0.84). MolNFT v1 #49553…

PDB
2QRQ
Type
protein
Length
808 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Glycogen phosphorylase, muscle form
EC
2.4.1.1
UniProt
P00489
Ligands
S13
Pockets
11 · best druggability 0.84

Structure

x-ray diffraction · 1 distinct chain · 53% helix, 15% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AGlycogen phosphorylase, muscle form (EC 2.4.1.1)protein80853% helix, 15% strandP00489

Ligands and binding sites

  • S13 · (3S,5R,7R,8S,9S,10R)-7-(hydroxymethyl)-3-(4-methylphenyl)-1,6-dioxa-2-azaspiro[4.5]decane-8,9,10-triol · ligand · chains A
  • DMS · Dimethyl sulfoxide · additive · 16 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

11 pockets found on a 1 Å grid, 4 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12650.840.9538S13
21230.780.9638empty
32580.690.8539empty
41190.550.8320empty
51930.500.7618DMS

Modifications

Observed in the structure: 1 modified (cofactor).

Compared structures

  • 2QRQ · Glycogen Phosphorylase b in complex with (1R)-3'-(4-methylphenyl)-spiro[1,5-anhydro-D-gluc… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.